Zevra Therapeutics (ZVRA) has issued an announcement.
Zevra Therapeutics, Inc. has entered into an agreement with Citizens JMP Securities LLC, under which it may offer up to $75 million of its common stock in an “at the market” offering. The sales agent will sell the stock based on the company’s instructions and receive a 3% commission. This arrangement follows the company’s decision to terminate its previous agreement with Citizens JMP Securities LLC and RBC Capital Markets, LLC as of July 12, 2024. The offering will be conducted under an effective shelf registration statement, and the sales are not guaranteed.
See more insights into ZVRA stock on TipRanks’ Stock Analysis page.
